The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Potential Involvement of Fas and Its Ligand in the Pathogenesis of Hashimoto's Thyroiditis
Abstract
The mechanisms responsible for thyrocyte destruction in Hashimoto's thyroiditis (HT) are poorly understood. Thyrocytes from HT glands, but not from nonautoimmune thyroids, expressed Fas. Interleukin-1β (IL-1β), abundantly produced in HT glands, induced Fas expression in normal thyrocytes, and cross-linking of Fas resulted in massive thyrocyte apoptosis. The ligand for Fas (FasL) was shown to be constitutively expressed both in normal and HT thyrocytes and was able to kill Fas-sensitive targets. Exposure to IL-1β induced thyrocyte apoptosis, which was prevented by antibodies that block Fas, suggesting that IL-1β-induced Fas expression serves as a limiting factor for thyrocyte destruction. Thus, Fas-FasL interactions among HT thyrocytes may contribute to clinical hypothyroidism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
Dhein, J., Walczak, H., Bäumler, C., Debatin, K.-M., & Krammer, P. H. (1995) · Nature · doi:10.1038/373438a0 · Cited by 1,609
A role for CD95 ligand in preventing graft rejection
Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A., & Duke, R. C. (1995) · Nature · doi:10.1038/377630a0 · Cited by 1,155
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.
Galle, P. R., Hofmann, W. J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, P. H., & Runkel, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1223 · Cited by 692
Autoimmune Thyroid Disease: Further Developments in Our Understanding*
WEETMAN, A. P., & McGREGOR, A. M. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-6-788 · Cited by 658
Leithäuser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Brüderlein, S., Henne, C., Schmidt, A., Debatin, K., Krammer, P. H., & Möller, P. (1993) · PubMed · Cited by 625
Liles, W. C., Kiener, P. A., Ledbetter, J. A., Aruffo, A., & Klebanoff, S. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.429 · Cited by 557
Dumont, J. E., Lamy, F., Roger, P., & Maenhaut, C. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.3.667 · Cited by 522
French, L. E., Hahne, M., Viard, I., Radlgruber, G., Zanone, R., Becker, K., Müller, C., & Tschopp, J. (1996) · The Journal of cell biology · doi:10.1083/jcb.133.2.335 · Cited by 448
Cifone, M. G., Roncaioli, P., De Maria, R., Camarda, G., Santoni, A., Ruberti, G., & Testi, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00274.x · Cited by 290
Self-citationThe Role of APO‐1‐Mediated Apoptosis in the Immune System
Krammer, P. H., Dhein, J., Walczak, H., Behrmann, I., Mariani, S., Matiba, B., Fath, M., Daniel, P. T., Knipping, E., Westendorp, M. O., et al. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00889.x · Cited by 225
Cascino, I., Papoff, G., De Maria, R., Testi, R., & Ruberti, G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.13 · Cited by 169
Self-citationGrubeck‐Loebenstein, B., Buchan, G. S., Chantry, D., Kassal, H., Londei, M., Pirich, K., Barrett, K., Turner, M., Waldhäusl, W. K., & Feldmann, M. (1989) · PubMed Central · Cited by 132
CELL POPULATION KINETICS IN DOG AND HUMAN ADULT THYROID
COCLET, J., Foureau, F., Ketelbant, P., Galand, P., & Dumont, J. E. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb01290.x · Cited by 129
Maria, R. D., Boirivant, M., Cifone, M. G., Roncaioli, P., Hahne, M., Tschopp, J., Pallone, F., Santoni, A., & Testi, R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118418 · Cited by 128
Self-citationThe times they are still a'changing: keeping up with the times.
Varki, A. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118375 · Cited by 87
Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disease
Wu, Z., Podack, E. R., McKenzie, J. M., Olsen, K. J., & Zakarija, M. (1994) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb05515.x · Cited by 71
Apoptosis in Dog Thyroid Cells
Dremier, S., GOLSTEIN, J., Mosselmans, R., Dumont, J. E., Galand, P., & Robaye, B. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1412 · Cited by 62
The Fas/APO-1 receptor and its deadly ligand
Schulze‐Osthoff, K. (1994) · Trends in Cell Biology · doi:10.1016/0962-8924(94)90102-3 · Cited by 50
CHAMPION, B. R., Cooke, A., & Rayner, D. C. (1992) · Current Opinion in Immunology · doi:10.1016/0952-7915(92)90060-r · Cited by 20
Cited by
Lymphocyte-Mediated Cytotoxicity
Russell, J. H., & Ley, T. J. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100201.131730 · Cited by 1,122
Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin
Viard, I., Wehrli, P., Bullani, R., Schneider, P., Holler, N., Salomon, D., Hunziker, T., Saurat, J.-H., Tschopp, J., & French, L. E. (1998) · Science · doi:10.1126/science.282.5388.490 · Cited by 1,005
Pearce, E. N., Farwell, A. P., & Braverman, L. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021194 · Cited by 878
Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A., & Green, D. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80054-4 · Cited by 721
Downregulation of Fas ligand by shedding
Tanaka, M., Itai, T., Adachi, M., & Nagata, S. (1998) · Nature Medicine · doi:10.1038/nm0198-031 · Cited by 669
Metadata
- Authors
- Giordano, C., Stassi, G., De Maria, R., Todaro, M., Richiusa, P., Papoff, G., Ruberti, G., Bagnasco, M., Testi, R., & Galluzzo, A.
- Venue
- Science
- Published
- 1997-02-14
- Volume
- 275
- Issue
- 5302
- Pages
- 960-963
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1514099677
- Cited by
- 582
- References
- 21
- FWCI
- 56.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.